Instadose Pharma (Instadose Pharma) Total Liabilities : $8.09 Mil (As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Total Liabilities?

Instadose Pharma's Total Liabilities for the quarter that ended in Feb. 2022 was $8.09 Mil.

Instadose Pharma's quarterly Total Liabilities increased from Aug. 2021 ($0.11 Mil) to Nov. 2021 ($0.17 Mil) and increased from Nov. 2021 ($0.17 Mil) to Feb. 2022 ($8.09 Mil).

Instadose Pharma's annual Total Liabilities increased from Nov. 2019 ($0.06 Mil) to Nov. 2020 ($0.08 Mil) and increased from Nov. 2020 ($0.08 Mil) to Nov. 2021 ($0.17 Mil).

Instadose Pharma Total Liabilities Historical Data

The historical data trend for Instadose Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Total Liabilities Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Total Liabilities

Get a 7-Day Free Trial

0.01

0.03

0.06

0.08

0.17

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Total Liabilities	Get a 7-Day Free Trial															0.01	0.06	0.11	0.17	8.09

Instadose Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Instadose Pharma's Total Liabilities for the fiscal year that ended in Nov. 2021 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.165	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.17

Total Liabilities	=	Total Assets (A: Nov. 2021 )	-	Total Equity (A: Nov. 2021 )
	=	N/A	-	-0.165
	=	N/A

Instadose Pharma's Total Liabilities for the quarter that ended in Feb. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8.025	+	(0.065	+	-0.00099999999999995
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	8.09

Total Liabilities	=	Total Assets (Q: Feb. 2022 )	-	Total Equity (Q: Feb. 2022 )
	=	36.142	-	28.053
	=	8.09

Instadose Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.